JPS6244526B2 - - Google Patents
Info
- Publication number
- JPS6244526B2 JPS6244526B2 JP54120437A JP12043779A JPS6244526B2 JP S6244526 B2 JPS6244526 B2 JP S6244526B2 JP 54120437 A JP54120437 A JP 54120437A JP 12043779 A JP12043779 A JP 12043779A JP S6244526 B2 JPS6244526 B2 JP S6244526B2
- Authority
- JP
- Japan
- Prior art keywords
- glucopyranoside
- ginsenoside
- stress
- mice
- glucopyranosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930182490 saponin Natural products 0.000 claims description 13
- 150000007949 saponins Chemical class 0.000 claims description 13
- 235000017709 saponins Nutrition 0.000 claims description 13
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 10
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 claims description 7
- 206010042209 Stress Diseases 0.000 claims description 7
- 235000008434 ginseng Nutrition 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 241000699670 Mus sp. Species 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 7
- 229960004373 acetylcholine Drugs 0.000 description 7
- 230000008602 contraction Effects 0.000 description 7
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 4
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000001198 duodenum Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229930182494 ginsenoside Natural products 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 3
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 206010043268 Tension Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- -1 methanol and ethanol Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- DLNAGMLXUYEHQS-UHFFFAOYSA-N 3-O-beta-D-glucopyranosylserjanic acid Natural products COC(=O)C1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6O)C(C)(C)C5CCC34C)C2C1)C(=O)O DLNAGMLXUYEHQS-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12043779A JPS5643214A (en) | 1979-09-19 | 1979-09-19 | Recovery agent for stress symptom accompanied by autonomic imbalance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12043779A JPS5643214A (en) | 1979-09-19 | 1979-09-19 | Recovery agent for stress symptom accompanied by autonomic imbalance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5643214A JPS5643214A (en) | 1981-04-21 |
| JPS6244526B2 true JPS6244526B2 (US08197722-20120612-C00042.png) | 1987-09-21 |
Family
ID=14786178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12043779A Granted JPS5643214A (en) | 1979-09-19 | 1979-09-19 | Recovery agent for stress symptom accompanied by autonomic imbalance |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5643214A (US08197722-20120612-C00042.png) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01215108A (ja) * | 1988-02-23 | 1989-08-29 | Nippon Dempa Kogyo Co Ltd | 圧電振動子 |
| JPH01227515A (ja) * | 1988-03-07 | 1989-09-11 | Nippon Dempa Kogyo Co Ltd | 圧電振動子 |
| JPH0266021U (US08197722-20120612-C00042.png) * | 1988-11-07 | 1990-05-18 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58193662A (ja) * | 1982-05-07 | 1983-11-11 | Tajuro Ueno | 栄養食料の製造方法 |
| JPS59227823A (ja) * | 1983-06-10 | 1984-12-21 | Takuo Kosuge | 補気薬 |
| JPS60184361A (ja) * | 1984-03-02 | 1985-09-19 | Ishibashi Kogyo Kk | 保健食品とその製造方法及び製造装置 |
| JPS60224454A (ja) * | 1984-04-23 | 1985-11-08 | Ishibashi Kogyo Kk | 保健食品の製造方法及び製造装置 |
| JPS60256354A (ja) * | 1984-11-19 | 1985-12-18 | Ishibashi Kogyo Kk | 保健食品とその製造方法 |
| CN103977281A (zh) * | 2014-05-22 | 2014-08-13 | 张囡囡 | 一种治疗女性内分泌失调的中药组合物及其制备方法 |
-
1979
- 1979-09-19 JP JP12043779A patent/JPS5643214A/ja active Granted
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01215108A (ja) * | 1988-02-23 | 1989-08-29 | Nippon Dempa Kogyo Co Ltd | 圧電振動子 |
| JPH01227515A (ja) * | 1988-03-07 | 1989-09-11 | Nippon Dempa Kogyo Co Ltd | 圧電振動子 |
| JPH0266021U (US08197722-20120612-C00042.png) * | 1988-11-07 | 1990-05-18 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5643214A (en) | 1981-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| De Tommasi et al. | Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica | |
| CH654483A5 (de) | Arzneimittel-praeparat zur besserung von krebssymptomen. | |
| JPS6325600B2 (US08197722-20120612-C00042.png) | ||
| JPS6244526B2 (US08197722-20120612-C00042.png) | ||
| EP0370284B1 (en) | A composition containing an extract obtained by a watercontaining organic solvent, and a process for preparing the same | |
| JPS6352013B2 (US08197722-20120612-C00042.png) | ||
| Yeşilada et al. | Anti-ulcerogenic effects of Spartium junceum flowers on in vivo test models in rats | |
| AU742556B2 (en) | Composition for improving mental capabilities in mammals | |
| BR112015001174B1 (pt) | composições para tratamento de fadiga relacionada ao câncer | |
| JP4421684B2 (ja) | 肥満防止剤及びその製造法 | |
| JPS6312445B2 (US08197722-20120612-C00042.png) | ||
| Singh et al. | A pharmacological evaluation of antistress activity of Diospyros peregrina Gurke | |
| WO2000078323A1 (fr) | Utilisation de l'icariine dans la preparation de medicaments pour la prevention et le traitement de troubles de l'erection et de maladies vasoconstrictrices | |
| JPS625126B2 (US08197722-20120612-C00042.png) | ||
| CN106822071A (zh) | 一种用于治疗冠心病、高脂血症的中药有效部位、制备方法及从中分离有效成分的方法 | |
| JPH04368359A (ja) | カプサイシン誘導体又はその酸エステルを有効成分とする鎮痛剤、血管拡張剤 | |
| JPS62132822A (ja) | 肝炎治療剤 | |
| JP3533231B2 (ja) | アルコール吸収抑制剤 | |
| JPS621372B2 (US08197722-20120612-C00042.png) | ||
| JPS6157808B2 (US08197722-20120612-C00042.png) | ||
| Boada et al. | Cardiac and extracardiac activity of an ethanolic extract of leaves of Isoplexis canariensis | |
| EP0950411B1 (de) | Verfahren zur Herstellung eines Extraktes aus Copalchirinde und Verwendung der Neoflavonoide zur Behandlung von Diabetes | |
| Anderson et al. | Isolation and characterization of and some observations on poisoning by bufadienolides from Cotyledon orbiculata L. var. orbiculata | |
| KR100202757B1 (ko) | 당뇨병 치료제 조성물 | |
| US3950518A (en) | Hypoglycemic composition and method of use |
